On the other hand, colorectal carcinoma patients presented a lower NFE2L2 expression with respect to the healthy tissue, while glioblastoma patients have a higher expression in comparison with healthy brain tissue samples (Supplementary Materials Figure S3B). The gene discussed is NFE2L2; the disease is glioblastoma.